Abstract:Tuberculosis, disease caused by Mycobacterium tuberculosis, is currently the leading cause of death by a single infectious agent worldwide. Early, rapid and accurate identification of M. tuberculosis and the determination of drug susceptibility is essential for the treatment and management of this disease. Tuberculosis diagnosis is mainly based on chest radiography, smear microscopy and bacteriological culture. Smear microscopy has variable sensitivity, mainly in patients co-infected with the human immunodeficiency virus (HIV). Conventional culture for M. tuberculosis isolation, identification and drug susceptibility testing requires several weeks owning to the slow growth of M. tuberculosis. The delay in the time to results drives the prolongation of potentially inappropriate antituberculosis therapy contributing to the emergence of drug resistance, reducing treatment options and increasing treatment duration and associated costs, resulting in increased mortality and morbidity. For these reasons, novel diagnostic methods are need for timely identification of M. tuberculosis and determination of the antibiotic susceptibility profile of the infecting strain. Molecular methods offer enhanced sensitivity and specificity, early detection and the capacity to detect mixed infections. These technologies have improved turnaround time, cost effectiveness and are amenable for point-of-care testing. However, although these methods produce results within hours from sample collection, the phenotypic susceptibility testing is still needed for the determination of drug susceptibility and quantify the susceptibility levels of a given strain towards individual antibiotics. This review presents the history, advances and forthcoming promises in the molecular diagnosis of tuberculosis. An overview on the general principles, diagnostic value and the main advantages and disadvantages of the molecular methods used for the detection and identification of M. tuberculosis and its associated disease, is provided. It will be also discussed how the current phenotypic methods should be used in combination with the genotypic methods for rapid antituberculosis susceptibility testing.

Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines

Perspectives on Development and Advancement of New Tuberculosis Vaccines

The past, present and future of tuberculosis treatment.

Innovative laboratory methods for improved tuberculosis diagnosis and drug-susceptibility testing

New developments in tuberculosis diagnosis and treatment

The changing landscape of diagnostic services for tuberculosis

[Diagnosis of tuberculosis in developing countries: new perspectives]

Scaling up interventions to achieve global tuberculosis control: progress and new developments

Advancing against drug-resistant tuberculosis: an extensive review, novel strategies and patent landscape

An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management

Challenges in the clinical assessment of novel tuberculosis drugs

Tuberculosis Diagnosis: Current, Ongoing, and Future Approaches

Nanomaterials in the Prevention, Diagnosis, and Treatment of Mycobacterium Tuberculosis Infections.

Recent advances and challenges of revolutionizing drug-resistant tuberculosis treatment

Tuberculosis: Current state of knowledge: An Epilogue

Advances in the molecular diagnosis of tuberculosis: From probes to genomes

Faster, Higher, Stronger: the Evolution of Clinical Perspectives on Pan-Tb

MDR/XDR-TB management of patients and contacts: Challenges facing the new decade. The 2020 clinical update by the Global Tuberculosis Network

Perspectives for systems biology in the management of tuberculosis

Scale-up of services and research priorities for diagnosis, management, and control of tuberculosis: a call to action

Improving the diagnosis of tuberculosis: old and new laboratory tools